By univariate analysis in both the overall population and the ER-low or negative, HER2– subgroup, PDX engraftment and RCB were associated with relapse, death of any cause, and death from breast cancer, with PDX engraftment best discriminating the patients at highest risk of an event (Appendix Table A1). Here, ESR1 is linked to breast carcinoma.